Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2014

01-10-2014 | Original Research

Identification of Germinal Centres in the Lymph Node of a Patient with Hyperimmunoglobulin M Syndrome Associated with Congenital Rubella

Authors: Rohan Ameratunga, Chun-Jen J. Chen, Wikke Koopmans, P. Rod Dunbar, Maia Brewerton, Richard Lloydd, Claudia J. Mansell, Chris van Vliet, See-Tarn Woon

Published in: Journal of Clinical Immunology | Issue 7/2014

Login to get access

Abstract

Background

The hyper immunoglobulin M syndrome (HIM) associated with congenital rubella infection (rHIM) is an extremely rare disorder, where patients have elevated serum IgM in association with reduced IgG and IgA. We have previously shown that in contrast to X-linked HIM (XHIM), a patient with well-characterised rHIM is able to express functional CD40 ligand, undergo immunoglobulin isotype switching and to generate memory B cells. Here we describe the ultrastructural features of an excised lymph node from this patient.

Methods

An inguinal lymph node was surgically removed and examined histologically as well as by immunohistochemistry. It was then stained with multiple fluorescent dyes to visualize the cellular interactions within the node. Flow cytometry was undertaken on a cellular suspension from the node.

Findings

Our patient has normal lymph node architecture by light microscopy. Immunohistochemistry studies showed the presence of scattered germinal centres. Polychromatic immunofluorescence staining showed disruption of the architecture with mostly abnormal germinal centres. A small number of relatively intact germinal centres were identified. Both IgM and IgG bearing cells were identified in germinal centres.

Interpretation

In contrast to XHIM where germinal centres are absent, the presence of small numbers of relatively normal germinal centres explain our previous identification of isotype switched memory B cells in rHIM.
Literature
1.
go back to reference Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3:101–21.PubMed Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3:101–21.PubMed
2.
go back to reference Ameratunga R et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr. 1997;131:147–50.PubMedCrossRef Ameratunga R et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr. 1997;131:147–50.PubMedCrossRef
3.
go back to reference Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol. 2006;117:855–64.PubMedCrossRef Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol. 2006;117:855–64.PubMedCrossRef
5.
go back to reference Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and prevention of congenital rubella syndrome–worldwide, 2009. J Infect Dis. 2011;204 Suppl 1:S24–27.PubMedCrossRef Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and prevention of congenital rubella syndrome–worldwide, 2009. J Infect Dis. 2011;204 Suppl 1:S24–27.PubMedCrossRef
6.
go back to reference Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis. 2006;43 Suppl 3:S123–125.PubMedCrossRef Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis. 2006;43 Suppl 3:S123–125.PubMedCrossRef
7.
go back to reference South MA, Montgomery JR, Rawls WE. Immune deficiency in congenital rubella and other viral infections. Birth Defects Orig Artic Ser. 1975;11:234–8.PubMed South MA, Montgomery JR, Rawls WE. Immune deficiency in congenital rubella and other viral infections. Birth Defects Orig Artic Ser. 1975;11:234–8.PubMed
8.
go back to reference Ribon A, Wasserman E. Immunodeficiency with congenital rubella. Ann Allergy. 1973;32:35–40.PubMed Ribon A, Wasserman E. Immunodeficiency with congenital rubella. Ann Allergy. 1973;32:35–40.PubMed
9.
go back to reference Cosachov JF. Hyper-IgM Syndrome with Congenital Rubella Pediatric Allergy, Asthma & Immunology. 1995;9:79–85. Cosachov JF. Hyper-IgM Syndrome with Congenital Rubella Pediatric Allergy, Asthma & Immunology. 1995;9:79–85.
10.
go back to reference Palacin PS et al. Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl. J Paediatr Child Health. 2007;43:716–8.PubMedCrossRef Palacin PS et al. Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl. J Paediatr Child Health. 2007;43:716–8.PubMedCrossRef
11.
go back to reference Benkerrou M, Gougeon ML. Griscelli, C. & Fischer, A. [Hypogammaglobulinemia G and A with hypergammaglobulinemia M. Apropos of 12 cases]. Arch Fr Pediatr. 1990;47:345–9.PubMed Benkerrou M, Gougeon ML. Griscelli, C. & Fischer, A. [Hypogammaglobulinemia G and A with hypergammaglobulinemia M. Apropos of 12 cases]. Arch Fr Pediatr. 1990;47:345–9.PubMed
12.
go back to reference Ameratunga R, Woon ST, Koopmans W, French J. Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection. J Clin Immunol. 2009;29:99–106.PubMedCrossRef Ameratunga R, Woon ST, Koopmans W, French J. Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection. J Clin Immunol. 2009;29:99–106.PubMedCrossRef
13.
go back to reference Stern LM, Forbes IJ. Dysgammaglobulinaemia and temporary immune paresis in a case of congenital rubella. Aust Paediatr J. 1975;11:38–41.PubMed Stern LM, Forbes IJ. Dysgammaglobulinaemia and temporary immune paresis in a case of congenital rubella. Aust Paediatr J. 1975;11:38–41.PubMed
14.
go back to reference Beausoleil J, Schwarz R, McGeady S. CD40 Ligand Expression in Immunodeficiency with Hyper IgM and Congenital Rubella Syndrome. Pediatric Asthma, Allergy & Immunology. 2000;14:225–30.CrossRef Beausoleil J, Schwarz R, McGeady S. CD40 Ligand Expression in Immunodeficiency with Hyper IgM and Congenital Rubella Syndrome. Pediatric Asthma, Allergy & Immunology. 2000;14:225–30.CrossRef
15.
go back to reference Ameratunga R et al. Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand. Clin Diagn Lab Immunol. 1996;3:722–6.PubMedPubMedCentral Ameratunga R et al. Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand. Clin Diagn Lab Immunol. 1996;3:722–6.PubMedPubMedCentral
16.
go back to reference Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 50, 1–23 (2001). Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 50, 1–23 (2001).
17.
go back to reference Bryan CF, Eastman PJ, Conner JB, Baier KA, Durham JB. Clinical utility of a lymph node normal range obtained by flow cytometry. Ann N Y Acad Sci. 1993;677:404–6.PubMedCrossRef Bryan CF, Eastman PJ, Conner JB, Baier KA, Durham JB. Clinical utility of a lymph node normal range obtained by flow cytometry. Ann N Y Acad Sci. 1993;677:404–6.PubMedCrossRef
18.
go back to reference Marshall WC, Cope WA, Soothill JF, Dudgeon JA. In vitro lymphocyte response in some immunity deficiency diseases and in intrauterine virus infections. Proc R Soc Med. 1970;63:351–4.PubMedPubMedCentral Marshall WC, Cope WA, Soothill JF, Dudgeon JA. In vitro lymphocyte response in some immunity deficiency diseases and in intrauterine virus infections. Proc R Soc Med. 1970;63:351–4.PubMedPubMedCentral
19.
go back to reference Singer DB, South MA, Montgomery JR, Rawls WE. Congenital rubella syndrome. Lymphoid tissue and immunologic status Am J Dis Child. 1969;118:54–61.CrossRef Singer DB, South MA, Montgomery JR, Rawls WE. Congenital rubella syndrome. Lymphoid tissue and immunologic status Am J Dis Child. 1969;118:54–61.CrossRef
20.
go back to reference Claman HN, Suvatte V, Githens JH, Hathaway WE. Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics. 1970;46:89–96.PubMed Claman HN, Suvatte V, Githens JH, Hathaway WE. Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics. 1970;46:89–96.PubMed
21.
go back to reference White LR et al. Immune competence in congenital rubella: lymphocyte transformation, delayed hypersensitivity, and response to vaccination. J Pediatr. 1968;73:229–34.PubMedCrossRef White LR et al. Immune competence in congenital rubella: lymphocyte transformation, delayed hypersensitivity, and response to vaccination. J Pediatr. 1968;73:229–34.PubMedCrossRef
22.
go back to reference Plotkin SA, Klaus RM, Whitely JP. Hypogammaglobulinemia in an infant with congenital rubella syndrome; failure of 1-adamantanamine to stop virus excretion. J Pediatr. 1966;69:1085–91.PubMedCrossRef Plotkin SA, Klaus RM, Whitely JP. Hypogammaglobulinemia in an infant with congenital rubella syndrome; failure of 1-adamantanamine to stop virus excretion. J Pediatr. 1966;69:1085–91.PubMedCrossRef
23.
go back to reference Hancock MP, Huntley CC, Sever JL. Congenital rubella syndrome with immunoglobulin disorder. J Pediatr. 1968;72:636–45.PubMedCrossRef Hancock MP, Huntley CC, Sever JL. Congenital rubella syndrome with immunoglobulin disorder. J Pediatr. 1968;72:636–45.PubMedCrossRef
24.
go back to reference Schimke RN, Bolano C, Kirkpatrick CH. Immunologic deficiency in the congenital rubella syndrome. Am J Dis Child. 1969;118:626–33.PubMed Schimke RN, Bolano C, Kirkpatrick CH. Immunologic deficiency in the congenital rubella syndrome. Am J Dis Child. 1969;118:626–33.PubMed
25.
go back to reference Revy P et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.PubMedCrossRef Revy P et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.PubMedCrossRef
26.
27.
go back to reference Soothill JF, Hayes K, Dudgeon JA. The immunoglobulins in congenital rubella. Lancet. 1966;1:1385–8.PubMedCrossRef Soothill JF, Hayes K, Dudgeon JA. The immunoglobulins in congenital rubella. Lancet. 1966;1:1385–8.PubMedCrossRef
28.
go back to reference Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol. 1995;154:6624–33. Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol. 1995;154:6624–33.
30.
go back to reference Atreya CD, Mohan KV, Kulkarni S. Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level. Birth Defects Res A Clin Mol Teratol. 2004;70:431–7.PubMedCrossRef Atreya CD, Mohan KV, Kulkarni S. Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level. Birth Defects Res A Clin Mol Teratol. 2004;70:431–7.PubMedCrossRef
31.
go back to reference Buimovici-Klein E, Lang PB, Ziring PR, Cooper LZ. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection. Pediatrics. 1979;64:620–6.PubMed Buimovici-Klein E, Lang PB, Ziring PR, Cooper LZ. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection. Pediatrics. 1979;64:620–6.PubMed
32.
go back to reference Minges Wols HA, Underhill GH, Kansas GS, Witte PL. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol. 2002;169:4213–21.PubMedCrossRef Minges Wols HA, Underhill GH, Kansas GS, Witte PL. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol. 2002;169:4213–21.PubMedCrossRef
33.
go back to reference Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev. 2012;247:52–63.PubMedCrossRef Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev. 2012;247:52–63.PubMedCrossRef
34.
go back to reference Michaels RH. Immunologic aspects of congenital rubella. Pediatrics. 1969;43:339–50.PubMed Michaels RH. Immunologic aspects of congenital rubella. Pediatrics. 1969;43:339–50.PubMed
35.
go back to reference Auner HW, Beham-Schmid C, Dillon N, Sabbattini P. The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress. Blood. 2010;116:3445–55.PubMedCrossRef Auner HW, Beham-Schmid C, Dillon N, Sabbattini P. The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress. Blood. 2010;116:3445–55.PubMedCrossRef
36.
go back to reference Dewan P, Gupta P. Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review. Indian Pediatr. 2012;49:377–99.PubMedCrossRef Dewan P, Gupta P. Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review. Indian Pediatr. 2012;49:377–99.PubMedCrossRef
Metadata
Title
Identification of Germinal Centres in the Lymph Node of a Patient with Hyperimmunoglobulin M Syndrome Associated with Congenital Rubella
Authors
Rohan Ameratunga
Chun-Jen J. Chen
Wikke Koopmans
P. Rod Dunbar
Maia Brewerton
Richard Lloydd
Claudia J. Mansell
Chris van Vliet
See-Tarn Woon
Publication date
01-10-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0084-6

Other articles of this Issue 7/2014

Journal of Clinical Immunology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.